IIM
OCUL icon

INTECH Investment Management’s Ocular Therapeutix OCUL Stock Holding History

INTECH Investment Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$642K Sell
75,843
-20,189
-21% -$192K 0.01% 1221
2025
Q4 		$1.17M Buy
96,032
+17,611
+22% +$214K 0.01% 1046
2025
Q3 		$917K Sell
78,421
-12,815
-14% -$153K 0.01% 1219
2025
Q2 		$847K Sell
91,236
-22,361
-20% -$175K 0.01% 1295
2025
Q1 		$833K Buy
113,597
+14,165
+14% +$109K 0.01% 1313
2024
Q4 		$849K Buy
99,432
+50,949
+105% +$497K 0.01% 1253
2024
Q3 		$422K Buy
+48,483
New +$400K ﹤0.01% 1322

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return